Replimune Group, Inc. (REPL)
14.71
-0.06
(-0.41%)
USD |
NASDAQ |
Aug 24, 16:00
14.69
-0.02
(-0.14%)
After-Hours: 20:00
Replimune Group Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -539.3% |
| Kalaris Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -137.2% |
| Return on Assets | -83.55% |
| Return on Invested Capital | -96.75% |
| Return on Net Operating Assets | -593.0% |